US2006134733A1PendingUtilityA1
Production of functional proteins: balance of shear stress and gravity
Est. expiryApr 8, 2017(expired)· nominal 20-yr term from priority
C12N 2310/13C12N 15/67C12N 2510/02C12N 5/0018C12N 2501/60C12N 15/113C12N 2310/315A61K 38/00
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides for a method of culturing cells and inducing the expression of at least one gene in the cell culture. The method provides for contacting the cell with a transcription factor decoy oligonucleotide sequence comprising a nucleotide sequence encoding a shear stress response element.
Claims
exact text as granted — not AI-modified1 - 26 . (canceled)
27 . A shear stress response element (SSRE) transcription factor decoy oligonucleotide comprising the nucleotide sequence selected from the group consisting of GAGACC and GGTCTC.
28 . The nucleotide of claim 27 , wherein said oligonucleotide comprises a terminal phosphothioate moiety and a phosphodiester backbone.
29 . The nucleotide of claim 27 , wherein said oligonucleotide is a contiguous single-stranded oligonucleotide comprising: i) a sequence selected from GAGACC and GGTCTC; and ii) a sequence compimentary to (i).
30 . The nucleotide of claim 27 , wherein said oligonucleotide consists of SEQ ID NO: 1.
31 . The nucleotide of claim 27 , wherein said oligonucleotide passes cell membranes and accumulates in the nuclear compartment of a cultured cell.
32 . The nucleotide of claim 31 wherein said cultured cell is grown in two dimensional culture.
33 . The nucleotide of claim 31 wherein said cultured cell is selected from the group consisting of an epithelial cell and an endothelial cell.
34 . The nucleotide of claim 31 wherein said cultured cell is selected from the group consisting of renal cortical cell, renal fibroblast cell, hepatocyte, pancreatic islet, renal interstitial cell, parathyroid cell, thyroid cell, pituitary cell, ovarian cell and testicular cell.
35 . A method of producing biomolecules comprising the steps of:
culturing at least one cell; contacting said cell with an SSRE transcription factor decoy oligonucleotide comprising a shear stress response element sequence selected from the group consisting of GAGACC and GGTCTC; and isolating biomolecules from the cell culture.
36 . The method of claim 35 , wherein said oligonucleotide comprises a terminal phosphothiorate phosphothioate moiety and a phosphodiester backbone.
37 . The method of claim 36 , wherein said oligonucleotide passes cell membranes and accumulates in the nuclear compartment of said cell.
38 . The method of claim 35 , wherein said cultured cell is selected from the group consisting of an epithelial cell and an endothelial cell.
39 . The method of claim 35 , wherein said cultured cell is selected from the group consisting of renal cortical cell, renal fibroblast cell, hepatocyte, pancreatic islet, renal interstitial cell, parathyroid cell, thyroid cell, pituitary cell, ovarian cell and testicular cell.
40 . The method of claim 35 , wherein said cultured cell is grown in two dimensional culture.
41 . The method of claim 35 , wherein said cultured cell is grown in a rotating wall vessel.
42 . The method of claim 35 , wherein the biomolecule is selected from the group consisting of megalin, cubulin, erythropoietin, 1-α-hydroxylase, and 1,25-dihydroxy-vitamin D3.
43 . A method of producing renal tubular epithelial cells from a cultured cell, comprising the steps of:
culturing at least one cell; contacting said cell with an SSRE transcription factor decoy oligonucleotide comprising a shear stress response element sequence selected from the group consisting of GAGACC and GGTCTC; and isolating differentiated renal tubular epithelial cells.
44 . The method of claim 43 , wherein said cultured cell is selected from the group consisting of an epithelial cell and an endothelial cell.
45 . The method of claim 43 , wherein said cultured cell is grown in a rotating wall vessel.
46 . The method of claim 43 , wherein the renal tubular epithelial cell produces biomolecules selected from the group consisting of megalin, cubulin, erythropoietin, 1-α-hydroxylase, and 1,25-dihydroxy-vitamin D3.Join the waitlist — get patent alerts
Track US2006134733A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.